Clopidogrel dilemma for orthopaedic surgeons

ANZ Journal of Surgery

Volumn 81, Issue 11, 2011, Pages 774-784

  Steele, Mitchell J ^a   Fox, John S ^b   Fletcher, John P ^c   Grigg, Leeanne E ^d   Bell, Gordon ^e  

^a WOLLONGONG HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antiplatelet aggregation inhibitor; Clopidogrel; Drug eluting stent; Orthopaedic procedure; Orthopaedics; Stent; Surgical blood loss; Thromboembolism; Thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

BLEEDING; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DECISION MAKING; DOSE RESPONSE; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; STANDARD; THROMBOSIS; TREATMENT OUTCOME;

ATTITUDE OF HEALTH PERSONNEL; BLOOD LOSS, SURGICAL; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 80055003742     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05631.x     Document Type: Review

References (70)

1. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J. Am. Coll. Cardiol. 2007; 49: 2145-50.
2. MIMS. MIMS Online. 2009 [updated 2009]; [Cited 29 Jun 2009.] Available from URL.
3. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
4. Coukell AJ, Markham A. Clopidogrel. Drugs 1997; 54: 745-50. discussion 51.
5. Desager JP. Clinical pharmacokinetics of ticlopidine. Clin. Pharmacokinet. 1994; 26: 347-55.
6. Plosker GL, Lyseng-Williamson KA. Clopidogrel: a review of its use in the prevention of thrombosis. Drugs 2007; 67: 613-46.
7. Murphy JT, Fahy BG. Balancing perioperative risks in orthopedic surgery: the patient with a coronary stent. Orthopedics 2007; 30: 931-6. quiz 7-8.
8. Gdalevich M, Cohen D, Yosef D, Tauber C. Morbidity and mortality after hip fracture: the impact of operative delay. Arch. Orthop. Trauma Surg. 2004; 124: 334-40.
9. Palan J, Odutola A, White SP. Is clopidogrel stopped prior to hip fracture surgery - A survey of current practice in the United Kingdom. Injury 2007; 38: 1279-85.
10. Joseph JJ, Pillai A, Bramley D. Clopidogrel in orthopaedic patients: a review of current practice in Scotland. Thromb. J. 2007; 5: 6.
11. Inman DS, Michla Y, Partington PF. Perioperative management of trauma patients admitted on clopidogrel (Plavix). A survey of orthopaedic departments across the United Kingdom. Injury 2007; 38: 625-30.
12. Lavelle WF, Demers Lavelle EA, Uhl R. Operative delay for orthopedic patients on clopidogrel (Plavix): a complete lack of consensus. J. Trauma 2008; 64: 996-1000.
13. Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J. Bone Joint Surg. Am. 2010; 92: 304-13.
14. Di Minno MN, Prisco D, Ruocco AL, Mastronardi P, Massa S, Di Minno G. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern. Emerg. Med. 2009; 4: 279-88.
15. Horlocker TT, Wedel DJ, Schroeder DR etal. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth. Analg. 1995; 80: 303-9.
16. Dunning J, Versteegh M, Fabbri A etal. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg. 2008; 34: 73-92.
17. Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy 2008; 28: 376-92.
18. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur. J. Cardiothorac. Surg. 2008; 34: 127-31.
19. Song SW, Youn YN, Yi G, Lee S, Yoo KJ. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome. Circ. J. 2008; 72: 626-32.
20. Karabulut H, Toraman F, Evrenkaya S, Goksel O, Tarcan S, Alhan C. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur. J. Cardiothorac. Surg. 2004; 25: 419-23.
21. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129: 734-7.
22. Brilakis ES, Banerjee S. Continuation of clopidogrel may be safe during bronchoscopy with biopsy?! Chest 2006; eletter. Available from URL.
23. Anielski R, Barczynski M. [Postoperative wound infections. II. Risk factors related to surgery]. Przegl. Lek. 1998; 55: 109-19.
24. Berbari EF, Hanssen AD, Duffy MC etal. Risk factors for prosthetic joint infection: case-control study. Clin. Infect. Dis. 1998; 27: 1247-54.
25. Saleh K, Olson M, Resig S etal. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J. Orthop. Res. 2002; 20: 506-15.
26. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does 'excessive' anticoagulation predispose to periprosthetic infection? J. Arthroplasty 2007; 22 (Suppl. 2): 24-8.
27. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br. J. Anaesth. 2007; 99: 316-28.
28. Wilson SH, Fasseas P, Orford JL etal. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J. Am. Coll. Cardiol. 2003; 42: 234-40.
29. Ho PM, Peterson ED, Wang L etal. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299: 532-9.
30. Spertus JA, Kettelkamp R, Vance C etal. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-9.
31. McFadden EP, Stabile E, Regar E etal. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
32. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter. Cardiovasc. Interv. 2005; 65: 516-9.
33. Park DW, Park SW, Park KH etal. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am. J. Cardiol. 2006; 98: 352-6.
34. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J. Am. Coll. Cardiol. 2005; 45: 2088-92.
35. Vaknin-Assa H, Assali A, Ukabi S, Lev EI, Kornowski R. Stent thrombosis following drug-eluting stent implantation. A single-center experience. Cardiovasc. Revasc. Med. 2007; 8: 243-7.
36. Rhee SJ, Yun KH, Lee SR etal. Drug-eluting stent thrombosis during perioperative period. Int. Heart J. 2008; 49: 135-42.
37. Barthwal R, Herman BA. Very late stent thrombosis after discontinuation of clopidogrel therapy. Med. J. Aust. 2008; 189: 229-30.
38. Zhang F, Qian J, Ge J. Very late stent thrombosis in late stent malapposition after sirolimus-eluting stent implantation. Int. Heart J. 2007; 48: 591-6.
39. Jamshidi P, Toggweiler S, Erne P. In-stent restenosis and thrombosis 41 months after drug-eluting stent implantation. Int. J. Cardiol. 2008; 130: e111-3.
40. Yang J, Wang N, Zhang X etal. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int. Heart J. 2006; 47: 707-13.
41. Puri A, Dwivedi S, Puri VK, Sethi R, Jain A. Very late angiographic stent thrombosis with cyphertrade mark stent despite being on aspirin therapy. Indian Heart J. 2006; 58: 61-4.
42. Lim SY, Kim KS, Joo SJ, Jeong MH. Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance. J. Korean Med. Sci. 2008; 23: 556-9.
43. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J. Am. Coll. Cardiol. 2005; 45: 1157-64.
44. Lemesle G, Delhaye C, Bonello L, de Labriolle A, Waksman R, Pichard A. Stent thrombosis in 2008: definition, predictors, prognosis and treatment. Arch. Cardiovasc. Dis. 2008; 101: 769-77.
45. Dalal AR, D'Souza S, Shulman MS. Brief review: coronary drug-eluting stents and anesthesia: [Article de synthese court: Les tuteurs coronariens actifs et l'anesthesie]. Can. J. Anaesth. 2006; 53: 1230-43.
46. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth. Analg. 1999; 89: 553-60.
47. Fleisher LA, Beckman JA, Brown KA etal. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth. Analg. 2008; 106: 685-712.
48. Douketis JD, Berger PB, Dunn AS etal. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl.): 299S-339S.
49. Al-Ani AN, Samuelsson B, Tidermark J etal. Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J. Bone Joint Surg. Am. 2008; 90: 1436-42.
50. Doruk H, Mas MR, Yildiz C, Sonmez A, Kyrdemir V. The effect of the timing of hip fracture surgery on the activity of daily living and mortality in elderly. Arch. Gerontol. Geriatr. 2004; 39: 179-85.
51. Ho CA, Li CY, Hsieh KS, Chen HF. Factors determining the 1-year survival after operated hip fracture: a hospital-based analysis. J. Orthop. Sci. 15: 30-7.
52. Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can. J. Anaesth. 2008; 55: 146-54.
53. Harty JA, McKenna P, Moloney D, D'Souza L, Masterson E. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J. Orthop. Surg. (Hong Kong) 2007; 15: 270-2.
54. Eisenstein EL, Anstrom KJ, Kong DF etal. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-68.
55. Grines CL, Bonow RO, Casey DE etal. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-8.
56. Butler MJ, Eccleston D, Clark DJ etal. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am. Heart J. 2009; 157: 899-907.
57. Solomon L, Warwick D, Nayagam S. Apley's Concise System of Orthopaedics and Fractures, 3rd edn. London: Hodder Arnold, 2005.
58. Canale ST, Beaty JH. Campbell's Operative Orthopaedics, 11th edn. Philadelphia, PA: Mosby/Elsevier, 2008.
59. Colwell CW, Hardwick ME. Thromboprophylaxis in elderly patients undergoing major orthopaedic surgery. Drugs Aging 2008; 25: 551-8.
60. Geerts WH, Bergqvist D, Pineo GF etal. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl.): 381S-453S.
61. Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst. Rev. 2002; (4): CD000305.
62. Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst. Rev. 2008; (4): CD005259.
63. Cochran K, DeMartini TJ, Lewis BE etal. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia. J. Invasive Cardiol. 2003; 15: 617-21.
64. Moon HJ, Kim JH, Kwon TH, Chung HS, Park YK. Spontaneous spinal epidural hematoma: an urgent complication of adding clopidogrel to aspirin therapy. J. Neurol. Sci. 2009; 285: 254-6.
65. Morales Ciancio RA, Drain O, Rillardon L, Guigui P. Acute spontaneous spinal epidural hematoma: an important differential diagnosis in patients under clopidogrel therapy. Spine J. 2008; 8: 544-7.
66. Sung JH, Hong JT, Son BC, Lee SW. Clopidogrel-induced spontaneous spinal epidural hematoma. J. Korean Med. Sci. 2007; 22: 577-9.
67. Broad L, Lee T, Conroy M etal. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br. J. Anaesth. 2007; 98: 19-22.
68. Bigalke B, Seizer P, Geisler T, Lindemann S, Gawaz M, May AE. Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery. Clin. Res. Cardiol. 2009; 98: 335-9.
69. Murkin JM, Lux J, Shannon NA etal. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J. Thorac. Cardiovasc. Surg. 1994; 107: 554-61.
70. Ouattara A, Bouzguenda H, Le Manach Y etal. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin. Eur. Heart J. 2007; 28: 1025-32.